Adipose tissue can resynthesize fat by combining fatty acids with glycerol.
The liver converts excess carbohydrates into acetyl CoA, which is then used for fatty acid synthesis and converted into triacylglycerol for distribution via lipoproteins.
Excess acetyl CoA in liver cells signals storage.
Citrate is transported into the cytosol to produce acetyl CoA.
Malonyl CoA production is the rate-limiting step.
Palmitate, a fatty acid, is generated with the addition of electrons via NADPH.
Palmitate is activated with CoA and combined with glycerol-3-phosphate to form triacylglycerol in the liver.
Triacylglycerol is packaged into lipoproteins for transport.
Lipoproteins consist of triacylglycerol, phospholipids, cholesterol, cholesterol esters, and proteins.
Very low-density lipoproteins (VLDL) are rich in fat.
Lipoproteins transport hydrophobic molecules in the bloodstream to power muscles via fatty acid cleavage by lipoprotein lipase or for triacylglycerol resynthesis in adipose tissue.
Proteins on the lipoprotein surface direct it to its target.
Phospholipids encapsulate hydrophobic molecules with their hydrophilic head groups and hydrophobic tails.
Insulin:
Produced in response to eating to store glucose as glycogen.
Stimulates adipose tissue to take in glucose and fatty acids for storage.
Glycerol-3-phosphate for triacylglycerol synthesis comes from glucose via glycolysis.
Glucagon:
Signals the need for fuel in a fasting state.
Activates protein kinase A (PKA) via a second messenger.
PKA phosphorylates hormone-sensitive lipase to break down stored fat.
The glucagon receptor is a G protein-coupled receptor.
These receptors are critical for drug design as they mediate cellular responses to external stimuli.
Binding of glucagon causes a conformational change, activating adenylyl cyclase to produce cyclic AMP (cAMP).
cAMP activates protein kinase A (PKA).
Adenylyl cyclase converts ATP to cyclic AMP, a stable signaling molecule.
Cyclic AMP activates protein kinase A, which phosphorylates hormone-sensitive lipase and perilipin to facilitate fat breakdown.
Fatty acids are released, bind to albumin proteins, and are transported to muscle cells for beta-oxidation.
Essential for cell membranes and is a precursor for bile salts and hormones.
It has both hydrophobic and hydrophilic properties due to its hydroxyl group (amphiphilic).
Obtained from diet and produced by the body but not used as an energy source.
Excreted via bile salts in the gastrointestinal system.
Transported in lipoproteins due to its insolubility in water.
High levels are associated with heart disease.
Inner core contains triacylglycerol and cholesterol esters.
Phospholipids and cholesterol associate with the surface.
Apoproteins (address markers) determine lipoprotein fate.
Classified by density: chylomicrons, VLDL, IDL, LDL, and HDL.
Chylomicrons transport dietary fats from the intestine to the liver and other tissues. Fatty acids are removed by lipoprotein lipase.
Smaller molecules are taken up by the liver.
VLDL (endogenous pathway): produced in the liver to deliver fats and cholesterol esters. As they travel through the bloodstream, fatty acids are removed resulting in LDL.
Sure!
- VLDL transports triglycerides (which contain fatty acids) from the liver to tissues for energy or fat storage. As it sheds triglycerides, it converts into LDL.
- LDL mainly delivers cholesterol to cells but can contribute to plaque buildup in arteries if excessive.
- Fatty acids impact these lipoproteins—saturated fats raise LDL, while unsaturated fats (like Omega-3) improve balance and heart health.
idl is temp carrier in lipid transport chain etween vldl and ldl
LDL binds to LDL receptors on cells, and cholesterol is utilized in membranes via endocytosis.
Excess cholesterol in cells leads to the removal of LDL receptors, increasing LDL levels and oxidation in the blood.
Oxidized LDL is consumed by macrophages, forming foam cells that accumulate on artery walls, leading to plaque formation.
HDL removes cholesterol from cell membranes and converts it to cholesterol esters.
HDL transfers cholesterol esters to other lipoproteins and they are taken up by the liver.
This reduces cellular cholesterol, promoting LDL receptor expression and LDL clearance.
HDL is considered "good cholesterol" as it reverses cholesterol buildup.
High LDL and low HDL levels increase the risk.
The Framingham Heart Study monitors risk factors for coronary heart disease.
Synthesized (generated) from acetyl CoA via mevalonate, isoprene, and squalene.
HMG CoA reductase is a key regulatory enzyme.
Regulated by phosphorylation and cholesterol levels (product inhibition).
High cholesterol levels can reduce sensitivity to negative feedback mechanisms (prevent enzyme function/produced).
Statins block the active site of HMG CoA reductase, reducing cholesterol production. (direct effect of statins)
Reduce VLDL production and increase LDL receptor production in the liver. (in direct effect of statins)
Side effects include muscle aches.
Data showing the effect of statins on personal cholesterol levels and ten-year risk of death.
Here are some key takeaways from the provided note on fat synthesis and storage, useful for exam revision:
Fatty Acid Synthesis: Understand how excess acetyl CoA is converted to fatty acids, with malonyl CoA production being the rate-limiting step.
Lipoproteins: Know the different types (VLDL, LDL, HDL), their composition, and their roles in transporting fats and cholesterol.
Insulin and Glucagon: Understand how these hormones regulate fat storage and breakdown.
Cholesterol: Remember its role in cell membranes, its transport via lipoproteins, and the implications of high LDL and low HDL levels.
HMG CoA Reductase and Statins: Know how cholesterol synthesis is regulated and how statins inhibit HMG CoA reductase to lower cholesterol levels.